AGREEMENT TO ASSIGN PATENT APPLICATIONSAgreement to Assign Patent Applications • August 9th, 2016 • Protagonist Therapeutics, Inc • Pharmaceutical preparations • New York
Contract Type FiledAugust 9th, 2016 Company Industry JurisdictionWHEREAS, the Parties have entered into a RESEARCH COLLABORATION AND LICENSE AGREEMENT dated as of June 16, 2012 as amended by Agreement on addition of Additional Collaboration Program, dated 16th September 2013 (“Collaboration Agreement”);
DATED 16 JUNE 2012 RESEARCH COLLABORATION AND LICENSE AGREEMENTResearch Collaboration and License Agreement • August 9th, 2016 • Protagonist Therapeutics, Inc • Pharmaceutical preparations • New York
Contract Type FiledAugust 9th, 2016 Company Industry Jurisdiction[*] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 406 of the Securities Act of 1933, as amended.
CONTRACT EXTENSION LETTER OF AGREEMENT hereinafter (“Contract Extension”) made effective as of June 1st 2013 (“Contract Extension Effective Date”).Contract Extension • August 9th, 2016 • Protagonist Therapeutics, Inc • Pharmaceutical preparations
Contract Type FiledAugust 9th, 2016 Company IndustryContract Extension to the RESEARCH COLLABORATION AND LICENSE AGREEMENT dated as of June 16, 2012 (the “Collaboration Agreement”) by and between
ContractAbandonment Agreement • August 9th, 2016 • Protagonist Therapeutics, Inc • Pharmaceutical preparations
Contract Type FiledAugust 9th, 2016 Company Industry[*] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 406 of the Securities Act of 1933, as amended.
Agreement on addition of Additional Collaboration Program hereinafter (“AACP”) made effective as of September 16th 2013 (“AACP Effective Date”).Addition of Additional Collaboration Program • August 9th, 2016 • Protagonist Therapeutics, Inc • Pharmaceutical preparations
Contract Type FiledAugust 9th, 2016 Company IndustryAddition of Additional Collaboration Program to the Research Plan, an integral part of the RESEARCH COLLABORATION AND LICENSE AGREEMENT dated as of June 16, 2012 (the “Collaboration Agreement”) by and between